Trial Profile
Risperidone vs. bupropion ER [extended release] augmentation of SSRIs [serotonin reuptake inhibitors] in treatment-resistant depression
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Risperidone (Primary) ; Bupropion
- Indications Major depressive disorder
- Focus Registrational; Therapeutic Use
- 01 Feb 2008 Status changed from in progress to completed according to NCT.
- 23 Oct 2006 New trial record.